I have no contribution in any part of all my lecture notes on slideshare, but I've just saved them as to make them ma favorites, then 2get them anywhere I go!!! Here, one 've 2know that I never let him/her save the lectures & Every body is blocked of downloading the notes! When you read the notes online GIVE PRIOR THANKS FOR MY INSTRUCTORS & I NEED NO THANKS !!! Omega Kifle
The document discusses synapses and the autonomic nervous system. It describes two types of synapses - chemical and electrical. The autonomic nervous system consists of the sympathetic and parasympathetic systems which regulate organs through the release of neurotransmitters like acetylcholine and norepinephrine. The effects of these systems are described for various organs. Drugs can act as agonists or antagonists at cholinergic and adrenergic receptors to influence the autonomic nervous system.
The document discusses drugs that affect the autonomic nervous system, specifically the sympathetic nervous system. It describes how drugs can stimulate or block receptors in the sympathetic nervous system. Sympathomimetic drugs like epinephrine stimulate receptors to increase heart rate, blood pressure, and bronchodilation. Sympatholytic drugs like alpha-adrenergic blockers antagonize norepinephrine and epinephrine, resulting in vasodilation and lower blood pressure. The document provides examples of drugs that target different receptors and their clinical uses for conditions like hypertension and asthma.
A good read for undergraduate students in Pharmacy studying at the University of Mumbai. I will highly recommend Essentials of Medical Pharmacology by KD Tripathi. All copyright to the original authors and publishers.
The document summarizes the autonomic nervous system (ANS), which is divided into the sympathetic and parasympathetic nervous systems. The sympathetic system uses norepinephrine as a neurotransmitter and activates the "fight or flight" response. The parasympathetic system uses acetylcholine and activates the "rest and digest" response. Cholinergic drugs stimulate the parasympathetic system while anticholinergic drugs block parasympathetic effects.
clinical pharmacology,clinical,injections,pharmacological,what is pharmacology,lethal injection drugs,pharmacology definition,Plus review of anatomy of the ANS
The document discusses the parasympathetic nervous system and parasympathomimetic drugs. It provides details on:
- The parasympathetic nervous system originates from the brainstem and sacral region and uses acetylcholine as a neurotransmitter.
- Parasympathomimetic drugs like acetylcholine, muscarine, and anticholinesterases act to stimulate parasympathetic responses. Direct acting drugs activate cholinergic receptors while indirect drugs inhibit acetylcholinesterase.
- These drugs have therapeutic uses for conditions like glaucoma, urinary retention, and myasthenia gravis. Combinations of drugs are sometimes used to achieve optimal effects while minimizing side effects.
The document discusses synapses and the autonomic nervous system. It describes two types of synapses - chemical and electrical. The autonomic nervous system consists of the sympathetic and parasympathetic systems which regulate organs through the release of neurotransmitters like acetylcholine and norepinephrine. The effects of these systems are described for various organs. Drugs can act as agonists or antagonists at cholinergic and adrenergic receptors to influence the autonomic nervous system.
The document discusses drugs that affect the autonomic nervous system, specifically the sympathetic nervous system. It describes how drugs can stimulate or block receptors in the sympathetic nervous system. Sympathomimetic drugs like epinephrine stimulate receptors to increase heart rate, blood pressure, and bronchodilation. Sympatholytic drugs like alpha-adrenergic blockers antagonize norepinephrine and epinephrine, resulting in vasodilation and lower blood pressure. The document provides examples of drugs that target different receptors and their clinical uses for conditions like hypertension and asthma.
A good read for undergraduate students in Pharmacy studying at the University of Mumbai. I will highly recommend Essentials of Medical Pharmacology by KD Tripathi. All copyright to the original authors and publishers.
The document summarizes the autonomic nervous system (ANS), which is divided into the sympathetic and parasympathetic nervous systems. The sympathetic system uses norepinephrine as a neurotransmitter and activates the "fight or flight" response. The parasympathetic system uses acetylcholine and activates the "rest and digest" response. Cholinergic drugs stimulate the parasympathetic system while anticholinergic drugs block parasympathetic effects.
clinical pharmacology,clinical,injections,pharmacological,what is pharmacology,lethal injection drugs,pharmacology definition,Plus review of anatomy of the ANS
The document discusses the parasympathetic nervous system and parasympathomimetic drugs. It provides details on:
- The parasympathetic nervous system originates from the brainstem and sacral region and uses acetylcholine as a neurotransmitter.
- Parasympathomimetic drugs like acetylcholine, muscarine, and anticholinesterases act to stimulate parasympathetic responses. Direct acting drugs activate cholinergic receptors while indirect drugs inhibit acetylcholinesterase.
- These drugs have therapeutic uses for conditions like glaucoma, urinary retention, and myasthenia gravis. Combinations of drugs are sometimes used to achieve optimal effects while minimizing side effects.
This document discusses cholinergic drugs and receptors. It describes two main types of cholinergic receptors - muscarinic and nicotinic receptors. It also classifies cholinergic drugs into direct-acting drugs like choline esters and alkaloids, and indirect-acting drugs that inhibit cholinesterase enzymes. Finally, it provides details on the properties and uses of some choline ester drugs like acetylcholine, bethanechol, carbachol, and methacholine.
drugs that affect the autonomic nervous system.ppt [autosaved] [autosaved]Sujit Karpe
This document provides an overview of the autonomic nervous system and discusses various adrenergic and cholinergic drugs. It defines the sympathetic and parasympathetic nervous systems and describes how adrenergic drugs stimulate the sympathetic system while cholinergic drugs stimulate the parasympathetic system. It then discusses the classification, mechanisms of action, effects and uses of various adrenergic and cholinergic drugs including catecholamines, alpha and beta receptor agonists and antagonists, anticholinesterases and direct acting cholinergic drugs. It also touches on myasthenia gravis and organophosphorus poisoning.
This document discusses drugs that act on the autonomic nervous system, specifically cholinergic and anticholinergic drugs. It begins by explaining that cholinergic drugs act on acetylcholine receptors, while anticholinergic drugs block these receptors. Acetylcholine is described as the neurotransmitter of the cholinergic system. Examples of direct and indirect acting cholinergic drugs are provided. Clinical uses and effects of specific cholinergic drugs like Bethanechol and Pilocarpine are summarized. Common anticholinergic drugs such as Atropine are also discussed in detail, outlining their mechanisms and therapeutic uses in conditions like peptic ulcer disease and asthma. Side effects of anticholinergic over
UNIT III_cholinergic neurotransmitter agonistSONALI PAWAR
The document discusses cholinergic neurotransmitters and parasympathomimetic agents. It begins by providing an overview of acetylcholine as the principal neurotransmitter of the parasympathetic nervous system. It then discusses the classification of parasympathomimetic agents into direct-acting agents like acetylcholine and indirect-acting agents like cholinesterase inhibitors. The document also covers the structure and mechanisms of several parasympathomimetic drugs including carbachol, bethanechol, methacholine, pilocarpine, physostigmine, and neostigmine. It concludes by describing the cholinergic receptors, muscarinic and nicotinic, and their distributions in the body.
This document provides an overview of adrenergic agents, including:
1) It defines adrenergic drugs as those that enhance or reduce activity of the sympathetic nervous system and discusses the sympathetic neurotransmitters epinephrine and norepinephrine.
2) It describes the types of adrenergic receptors (alpha and beta), their locations, and effects of stimulating each receptor type.
3) It discusses sympatholytic and sympathomimetic drugs, including examples of each type and their therapeutic uses.
Pharmacology parasympathetic nervous system- in briefraj kumar
The parasympathetic nervous system functions to conserve energy and promote rest. It decreases heart rate and promotes secretions from glands. Acetylcholine is the primary neurotransmitter and binds to nicotinic receptors in the autonomic ganglia and muscarinic receptors in effector tissues. Parasympathetic stimulation contracts the iris sphincter muscle to accommodate vision.
The document discusses the nervous system, specifically focusing on the peripheral nervous system (PNS) and its divisions - the autonomic nervous system (ANS) and somatic nervous system. It provides details on the ANS, including its sympathetic and parasympathetic divisions. The parasympathetic system uses acetylcholine as its neurotransmitter which acts on nicotinic and muscarinic receptors. Cholinergic drugs that act as parasympathomimetics are used to treat various conditions like glaucoma. Pilocarpine is commonly used as a parasympathomimetic eye drop to reduce intraocular pressure in glaucoma by contracting the ciliary muscle and increasing drainage of aqueous humor through the trabecular
Introduction
parasympathetic nervous system
cholinergic drugs
Anticholinergic agents
Divisions of Autonomous nervous system
Drugs acting on adrenergic nervous system
Adrenergic agents
The content starts from brief introduction to nervous system. Introduction to adrenergic nervous system and cholinergic nervous system, classification, mechanism of action, receptors, classification including agonists and antagonists, structure activity relationships, therapeutic uses. This content is prepared by using various books and internet sources.
Autonomic nervous system introduction and cholinergic systemDr. Siddhartha Dutta
This document discusses the autonomic nervous system (ANS) and cholinergic drugs. It begins by describing the ANS and its role in regulating vital functions. Acetylcholine is the primary neurotransmitter of the parasympathetic nervous system. Cholinergic drugs such as acetylcholine esters and anticholinesterases work by increasing acetylcholine levels in the body. Anticholinesterases inhibit the acetylcholinesterase enzyme, preventing the breakdown of acetylcholine. These drugs have applications in conditions like glaucoma, Alzheimer's disease, and myasthenia gravis.
The document discusses adrenergic drugs and the sympathetic nervous system. It describes how norepinephrine is released from sympathetic neurons and activates alpha and beta adrenergic receptors, producing various effects. Norepinephrine is stored in vesicles and released into synapses, where it can activate presynaptic receptors or bind to postsynaptic receptors on target organs. It is then largely reabsorbed or broken down. Adrenergic drugs can mimic norepinephrine by activating these receptors, and are used for conditions like low blood pressure and asthma.
The document discusses the sympathetic nervous system and adrenergic receptors. It describes:
1) How catecholamines like norepinephrine and epinephrine are synthesized from phenylalanine and tyrosine and stored in vesicles for release.
2) The different types of adrenergic receptors - alpha1, alpha2, beta1, beta2, and beta3 - and their locations and effects.
3) How catecholamines are released from neurons upon stimulation and their actions on various organs via receptor activation or reuptake.
Part II: UNIT cholinergic neurotransmitter - Antagonist DrugsSONALI PAWAR
This document discusses cholinergic neurotransmitters and cholinergic blocking agents. It begins by describing various cholinergic blocking agents including solanaceous alkaloids like atropine, scopolamine, and hyoscyamine as well as synthetic agents like tropicamide, cyclopentolate, dicyclomine, glycopyrrolate, and propantheline. It then discusses the mechanisms of action and medical uses of these drugs, which work by antagonizing acetylcholine at nicotinic or muscarinic receptors. The document also covers structural activity relationships of parasympatholytic agents and their use in treating conditions like smooth muscle spasms, ulcers, overactive bladder, and Parkinson
The document discusses the pharmacology of the autonomic nervous system. It describes how the sympathetic and parasympathetic divisions typically function in opposition to prepare the body for fight or flight responses versus rest and digestion. Acetylcholine is the neurotransmitter for preganglionic and parasympathetic fibers, while norepinephrine is released by postganglionic sympathetic fibers. Muscarinic and nicotinic receptors mediate the effects of acetylcholine. Cholinergic drugs can either directly activate these receptors or indirectly inhibit acetylcholinesterase to increase endogenous acetylcholine levels.
The medicinal chemistry aspect of Adrenergic (Sympathetic) Nervous System and drugs (Sympathomimetics & sympatholytics) are briefly explained in these slides.
This document provides information about adrenergic drugs. It begins with an introduction to adrenergic receptor subtypes and how their distribution affects organ responses. It then discusses the effects of three specific adrenergic drugs: epinephrine, norepinephrine, and dopamine. Epinephrine is described as having prominent cardiovascular effects including increasing blood pressure and cardiac output. Norepinephrine is a potent vasopressor that mainly increases blood pressure through vasoconstriction. Dopamine can cause vasodilation at low doses by interacting with D1 receptors. The document covers the vascular, cardiac, smooth muscle, metabolic and other effects of each drug in detail.
1. The document discusses the adrenergic system, including synthesis, storage, release, and metabolism of catecholamines like norepinephrine and epinephrine. It also describes alpha and beta adrenergic receptors.
2. Various adrenergic drugs are discussed, including their uses as nasal decongestants, anorectics, and for conditions like hypotension, cardiac issues, asthma, allergies, and more.
3. The therapeutic uses section outlines uses of adrenergic drugs for vascular issues, cardiac arrest, bronchodilation, allergies, mydriasis, and some central nervous system conditions.
The nervous system controls all major body functions and is divided into central and peripheral systems. The peripheral system includes the somatic and autonomic systems. The autonomic nervous system (ANS) controls involuntary functions like circulation, respiration, digestion and temperature regulation. It is divided into the sympathetic and parasympathetic systems which use norepinephrine and acetylcholine as neurotransmitters respectively. Adrenergic drugs mimic sympathetic effects by stimulating adrenergic receptors, while anticholinergic drugs block parasympathetic effects by blocking cholinergic receptors. These receptor systems allow drugs to selectively target specific organ systems.
This document discusses cholinergic drugs and receptors. It describes two main types of cholinergic receptors - muscarinic and nicotinic receptors. It also classifies cholinergic drugs into direct-acting drugs like choline esters and alkaloids, and indirect-acting drugs that inhibit cholinesterase enzymes. Finally, it provides details on the properties and uses of some choline ester drugs like acetylcholine, bethanechol, carbachol, and methacholine.
drugs that affect the autonomic nervous system.ppt [autosaved] [autosaved]Sujit Karpe
This document provides an overview of the autonomic nervous system and discusses various adrenergic and cholinergic drugs. It defines the sympathetic and parasympathetic nervous systems and describes how adrenergic drugs stimulate the sympathetic system while cholinergic drugs stimulate the parasympathetic system. It then discusses the classification, mechanisms of action, effects and uses of various adrenergic and cholinergic drugs including catecholamines, alpha and beta receptor agonists and antagonists, anticholinesterases and direct acting cholinergic drugs. It also touches on myasthenia gravis and organophosphorus poisoning.
This document discusses drugs that act on the autonomic nervous system, specifically cholinergic and anticholinergic drugs. It begins by explaining that cholinergic drugs act on acetylcholine receptors, while anticholinergic drugs block these receptors. Acetylcholine is described as the neurotransmitter of the cholinergic system. Examples of direct and indirect acting cholinergic drugs are provided. Clinical uses and effects of specific cholinergic drugs like Bethanechol and Pilocarpine are summarized. Common anticholinergic drugs such as Atropine are also discussed in detail, outlining their mechanisms and therapeutic uses in conditions like peptic ulcer disease and asthma. Side effects of anticholinergic over
UNIT III_cholinergic neurotransmitter agonistSONALI PAWAR
The document discusses cholinergic neurotransmitters and parasympathomimetic agents. It begins by providing an overview of acetylcholine as the principal neurotransmitter of the parasympathetic nervous system. It then discusses the classification of parasympathomimetic agents into direct-acting agents like acetylcholine and indirect-acting agents like cholinesterase inhibitors. The document also covers the structure and mechanisms of several parasympathomimetic drugs including carbachol, bethanechol, methacholine, pilocarpine, physostigmine, and neostigmine. It concludes by describing the cholinergic receptors, muscarinic and nicotinic, and their distributions in the body.
This document provides an overview of adrenergic agents, including:
1) It defines adrenergic drugs as those that enhance or reduce activity of the sympathetic nervous system and discusses the sympathetic neurotransmitters epinephrine and norepinephrine.
2) It describes the types of adrenergic receptors (alpha and beta), their locations, and effects of stimulating each receptor type.
3) It discusses sympatholytic and sympathomimetic drugs, including examples of each type and their therapeutic uses.
Pharmacology parasympathetic nervous system- in briefraj kumar
The parasympathetic nervous system functions to conserve energy and promote rest. It decreases heart rate and promotes secretions from glands. Acetylcholine is the primary neurotransmitter and binds to nicotinic receptors in the autonomic ganglia and muscarinic receptors in effector tissues. Parasympathetic stimulation contracts the iris sphincter muscle to accommodate vision.
The document discusses the nervous system, specifically focusing on the peripheral nervous system (PNS) and its divisions - the autonomic nervous system (ANS) and somatic nervous system. It provides details on the ANS, including its sympathetic and parasympathetic divisions. The parasympathetic system uses acetylcholine as its neurotransmitter which acts on nicotinic and muscarinic receptors. Cholinergic drugs that act as parasympathomimetics are used to treat various conditions like glaucoma. Pilocarpine is commonly used as a parasympathomimetic eye drop to reduce intraocular pressure in glaucoma by contracting the ciliary muscle and increasing drainage of aqueous humor through the trabecular
Introduction
parasympathetic nervous system
cholinergic drugs
Anticholinergic agents
Divisions of Autonomous nervous system
Drugs acting on adrenergic nervous system
Adrenergic agents
The content starts from brief introduction to nervous system. Introduction to adrenergic nervous system and cholinergic nervous system, classification, mechanism of action, receptors, classification including agonists and antagonists, structure activity relationships, therapeutic uses. This content is prepared by using various books and internet sources.
Autonomic nervous system introduction and cholinergic systemDr. Siddhartha Dutta
This document discusses the autonomic nervous system (ANS) and cholinergic drugs. It begins by describing the ANS and its role in regulating vital functions. Acetylcholine is the primary neurotransmitter of the parasympathetic nervous system. Cholinergic drugs such as acetylcholine esters and anticholinesterases work by increasing acetylcholine levels in the body. Anticholinesterases inhibit the acetylcholinesterase enzyme, preventing the breakdown of acetylcholine. These drugs have applications in conditions like glaucoma, Alzheimer's disease, and myasthenia gravis.
The document discusses adrenergic drugs and the sympathetic nervous system. It describes how norepinephrine is released from sympathetic neurons and activates alpha and beta adrenergic receptors, producing various effects. Norepinephrine is stored in vesicles and released into synapses, where it can activate presynaptic receptors or bind to postsynaptic receptors on target organs. It is then largely reabsorbed or broken down. Adrenergic drugs can mimic norepinephrine by activating these receptors, and are used for conditions like low blood pressure and asthma.
The document discusses the sympathetic nervous system and adrenergic receptors. It describes:
1) How catecholamines like norepinephrine and epinephrine are synthesized from phenylalanine and tyrosine and stored in vesicles for release.
2) The different types of adrenergic receptors - alpha1, alpha2, beta1, beta2, and beta3 - and their locations and effects.
3) How catecholamines are released from neurons upon stimulation and their actions on various organs via receptor activation or reuptake.
Part II: UNIT cholinergic neurotransmitter - Antagonist DrugsSONALI PAWAR
This document discusses cholinergic neurotransmitters and cholinergic blocking agents. It begins by describing various cholinergic blocking agents including solanaceous alkaloids like atropine, scopolamine, and hyoscyamine as well as synthetic agents like tropicamide, cyclopentolate, dicyclomine, glycopyrrolate, and propantheline. It then discusses the mechanisms of action and medical uses of these drugs, which work by antagonizing acetylcholine at nicotinic or muscarinic receptors. The document also covers structural activity relationships of parasympatholytic agents and their use in treating conditions like smooth muscle spasms, ulcers, overactive bladder, and Parkinson
The document discusses the pharmacology of the autonomic nervous system. It describes how the sympathetic and parasympathetic divisions typically function in opposition to prepare the body for fight or flight responses versus rest and digestion. Acetylcholine is the neurotransmitter for preganglionic and parasympathetic fibers, while norepinephrine is released by postganglionic sympathetic fibers. Muscarinic and nicotinic receptors mediate the effects of acetylcholine. Cholinergic drugs can either directly activate these receptors or indirectly inhibit acetylcholinesterase to increase endogenous acetylcholine levels.
The medicinal chemistry aspect of Adrenergic (Sympathetic) Nervous System and drugs (Sympathomimetics & sympatholytics) are briefly explained in these slides.
This document provides information about adrenergic drugs. It begins with an introduction to adrenergic receptor subtypes and how their distribution affects organ responses. It then discusses the effects of three specific adrenergic drugs: epinephrine, norepinephrine, and dopamine. Epinephrine is described as having prominent cardiovascular effects including increasing blood pressure and cardiac output. Norepinephrine is a potent vasopressor that mainly increases blood pressure through vasoconstriction. Dopamine can cause vasodilation at low doses by interacting with D1 receptors. The document covers the vascular, cardiac, smooth muscle, metabolic and other effects of each drug in detail.
1. The document discusses the adrenergic system, including synthesis, storage, release, and metabolism of catecholamines like norepinephrine and epinephrine. It also describes alpha and beta adrenergic receptors.
2. Various adrenergic drugs are discussed, including their uses as nasal decongestants, anorectics, and for conditions like hypotension, cardiac issues, asthma, allergies, and more.
3. The therapeutic uses section outlines uses of adrenergic drugs for vascular issues, cardiac arrest, bronchodilation, allergies, mydriasis, and some central nervous system conditions.
The nervous system controls all major body functions and is divided into central and peripheral systems. The peripheral system includes the somatic and autonomic systems. The autonomic nervous system (ANS) controls involuntary functions like circulation, respiration, digestion and temperature regulation. It is divided into the sympathetic and parasympathetic systems which use norepinephrine and acetylcholine as neurotransmitters respectively. Adrenergic drugs mimic sympathetic effects by stimulating adrenergic receptors, while anticholinergic drugs block parasympathetic effects by blocking cholinergic receptors. These receptor systems allow drugs to selectively target specific organ systems.
The document discusses drugs that act on the autonomic nervous system, including:
- Adrenergic drugs that stimulate the sympathetic nervous system by mimicking norepinephrine and epinephrine. This includes both catecholamines and non-catecholamines.
- Adrenergic blockers that block the actions of norepinephrine and epinephrine at adrenergic receptor sites. This includes both alpha-blockers and beta-blockers.
- Cholinergic drugs that stimulate the parasympathetic nervous system by mimicking acetylcholine, and anticholinergic drugs that block acetylcholine's actions. Cholinergic drugs can be direct-acting or indirect-
Sympathomimetic drugs mimic the effects of endogenous agonists of the sympathetic nervous system like epinephrine and norepinephrine. They can be classified based on their chemical nature, mode of action, receptor activation, and therapeutic use. Examples include catecholamines like epinephrine and norepinephrine, as well as non-catecholamines. These drugs work by directly or indirectly activating alpha and beta receptors. Common uses include treatment of hypotension, bronchodilation for asthma, and cardiac stimulation. While helpful medications, they can also cause adverse effects like high blood pressure, arrhythmias, and anxiety if not carefully monitored.
The document discusses the autonomic nervous system, describing the parasympathetic and sympathetic divisions. It explains that the parasympathetic nervous system uses acetylcholine as its neurotransmitter and targets muscarinic and nicotinic receptors, while the sympathetic nervous system uses norepinephrine and epinephrine as neurotransmitters. The actions of the sympathetic and parasympathetic systems are contrasted, with the sympathetic system preparing the body for "fight or flight" and the parasympathetic inducing "rest and digest".
This document discusses the autonomic nervous system. It begins by defining the somatic and autonomic nervous systems, and their components. It then compares the somatic and autonomic nervous systems. The functions of the sympathetic and parasympathetic nervous systems are described. Cholinergic and adrenergic receptors are explained. The document concludes by discussing cholinergic and adrenergic drugs, including their classifications, mechanisms of action, uses and side effects.
This document discusses the autonomic nervous system. It begins by defining the sympathetic and parasympathetic nervous systems, their functions, and the types of receptors they act on. It then covers cholinergic and adrenergic neurotransmission in more detail. The rest of the document discusses cholinergic and adrenergic drugs, including cholinomimetics, anticholinesterases, antimuscarinics, adrenomimetics, and adrenoceptor antagonists. Key therapeutic uses and side effects of various drugs are provided as examples.
The document discusses drugs that act on the autonomic nervous system, including cholinergic drugs. It describes how acetylcholine is the main neurotransmitter of the parasympathetic nervous system. Cholinergic drugs can either directly activate cholinergic receptors as agonists or indirectly increase acetylcholine levels by inhibiting the acetylcholinesterase enzyme. Direct agonists include choline esters and alkaloids which have longer duration than acetylcholine. Indirect agonists are reversible inhibitors like neostigmine or irreversible inhibitors such as organophosphates that can cause toxic effects by persistently increasing acetylcholine levels. These drugs have various therapeutic uses as well as adverse effects depending on their mechanism and selectivity
This document discusses the autonomic nervous system and cholinergic transmission. It describes how drugs can have parasympathomimetic or parasympatholytic effects by stimulating or opposing muscarinic receptors. There are three main types of muscarinic receptors (M1, M2, M3) located throughout the body. Drugs that stimulate muscarinic receptors can be direct acting parasympathomimetics or indirect acting via inhibiting acetylcholinesterase. Common cholinergic drugs and their effects/indications are also outlined.
This document discusses cholinergic drugs, which are drugs that stimulate the parasympathetic nervous system. It describes how cholinergic drugs mimic the effects of the neurotransmitter acetylcholine and can be either direct-acting or indirect-acting. Direct-acting drugs bind directly to cholinergic receptors while indirect drugs inhibit the enzyme acetylcholinesterase. Common effects include increased gastrointestinal and urinary function, bronchial constriction, decreased heart rate, and more. The document outlines specific cholinergic drugs, their mechanisms and uses, as well as adverse effects like nausea and hypotension that can occur with overstimulation of the parasympathetic nervous system. It also discusses anticholinergic drugs that block choliner
Ketamine is a dissociative anesthetic agent that was first used in humans in 1965. It acts as an NMDA receptor antagonist and also interacts with voltage gated sodium channels. Ketamine produces dissociative anesthesia and profound analgesia by inhibiting the cortex and thalamus while stimulating the limbic system. It has a rapid onset of action of 30-60 seconds and is metabolized primarily in the liver before being excreted by the kidneys. Common side effects include increased heart rate and blood pressure as well as emergence reactions like hallucinations. Ketamine can interact with other drugs to increase the risk of seizures or potentiate muscle relaxants and depress the heart.
Ketamine is a dissociative anesthetic that was first used in humans in 1965. It acts as an NMDA receptor antagonist and also interacts with voltage gated sodium channels. Ketamine produces dissociative anesthesia and profound analgesia by inhibiting the cortex and thalamus while stimulating the limbic system. It has a rapid onset of action of 30-60 seconds and is metabolized primarily in the liver before being excreted by the kidneys. Common side effects include increased heart rate and blood pressure as well as emergence reactions like hallucinations. Ketamine can interact with other drugs to increase risks of seizures or potentiate muscle relaxants.
This document summarizes parasympathomimetics (cholinergic agonists). It discusses how the parasympathetic nervous system uses acetylcholine as a neurotransmitter and how cholinergic agonists mimic acetylcholine's actions. It classifies cholinergic agonists into direct-acting and indirect-acting types. Direct agonists bind receptors, while indirect agonists inhibit acetylcholinesterase to increase acetylcholine levels. Examples of both types are provided along with their structures, mechanisms of action, and uses. The document also covers acetylcholine synthesis and catabolism as well as structure-activity relationships of parasympathomimetics.
2 Pharmacology I, intro ANS cholinergic drugs.pptxAhmad Kharousheh
The document provides an overview of the autonomic nervous system, describing the two divisions of the sympathetic and parasympathetic nervous systems. It explains the neurotransmitters involved, including acetylcholine and norepinephrine, and the receptors they act on. The document also discusses the classes of drugs that act on the autonomic nervous system, including direct-acting cholinergic agonists, indirect-acting cholinergic agonists that inhibit acetylcholinesterase, and antimuscarinic drugs that block muscarinic receptors.
The document provides an overview of the autonomic nervous system and cholinergic system. It discusses how acetylcholine is the neurotransmitter of the parasympathetic nervous system and cholinergic fibers. It describes the two classes of cholinergic receptors - muscarinic and nicotinic receptors. It also summarizes several cholinergic drugs, including direct-acting cholinergic drugs like acetylcholine, and indirect-acting anticholinesterase drugs.
Autonomic nervous system ( by Dr. Takele Beyene,DVM,MSc,@AAU)
1. Neuropharmacology
By
Takele Beyene
Department of Biomedical Sciences
College of V t Medicine & Agriculture
C ll f Vet. M di i A i lt
Addis Ababa University
y
2. Basic Anatomy and Physiology of NS
Two parts of the nervous system (NS)
CNS (central): brain and spinal cord
( ) p
PNS (Peripheral):
Afferent (sensory) neurons (SN)
Efferent (motor) neurons (MN) = Somatic NS and
Autonomic Ns
Basic unit of the nervous system = neuron
Sensory, Associative, Motor
Parts of the neuron
Cell b d Dendrite, Axon
body, Dendrite A n
Afferent neurons, which carry nerve impulses into the CNS from
sensory end organs in peripheral tissues, and
y g p p ,
Efferent neurons, which carry nerve impulses from the CNS to
effector cells in peripheral tissues.
2
3. Topics to be covered
I. Pharmacology of Autonomic & Somatic Nervous
System
II. Drugs acting on Central Nervous System
General and Local Anesthetics (techniques and
types)
3
4. I. Pharmacology of Autonomic and Somatic
Nervous System
Learning Objectives
Anatomy and functions of the ANS
Neurotransmitters in ANS
Cholinergics and Anticholinergics
Adrenergics and Antiadrenergics
4
5. Introduction to ANS
ANS also called the visceral, vegetative, or
, g ,
involuntary nervous system
distributed widely throughout the body and regulates
autonomic functions
consists of nerves, ganglia, and plexuses
innervate the heart blood vessels glands other
heart, vessels, glands,
visceral organs, and smooth muscle in various tissues.
5
7. Visceral Afferent Fibers….cont’d
• Two main sensory systems:
– Cranial (parasympathetic) visceral sensory system
and
– spinal (sympathetic) visceral afferent system
Cranial visceral sensory system carries
mechanoreceptor & chemosensory information
7
8. Central Autonomic Connections
Hypothalamus generally are regarded as principal loci of
integration of ANS functions, which include regulation of:
Body t
B d temperaturet
Water balance
Carbohydrate and fat metabolism
Blood pressure
Emotions
Sleep
Respiration, and
Reproduction
8
9. Peripheral Autonomic System (PAS)
Two l
T large di i i
divisions:
(1) the sympathetic or thoracolumbar outflow and
(2) the parasympathetic or craniosacral outflow
9
11. Autonomic Nervous System(ANS)
Sympathetic (Adrenergic): “fight or flight”
Increases heart rate, respiration rate, and blood flow to
p
muscles;
decreases GI function;
causes pupillary dilation
p p y
Preganglionic synapse: ACh;
postganglionic synapse: epi or norepi
Parasympathetic (Cholinergic): “homeostatic”
Brings heart rate, respiration rate, and blood flow to
muscles back to normal levels;
l b k ll l
returns GI function to normal;
constricts pupils to normal size
Pre- and postganglionic synapse: ACh
11
12. Antagonistic
Control
• Most internal organs are
innervated by both branches of
the ANS which exhibit
antagonistic control
A great example is heart rate.
An increase in sympathetic
stimulation causes HR to
increase whereas an increase in
parasympathetic
th ti stimulation
ti l ti
causes HR to decrease
12
13. Exception to the dual innervation rule:
Sweat glands and blood vessel smooth muscle are
only innervated by sympathetic and rely strictly on
.
Exception to the antagonism rule:
Sympathetic and parasympathetic work
cooperatively to achieve male sexual function.
Parasympathetic is responsible for erection while
sympathetic is responsible to ejaculation.
13
14. NEUROTRANSMISSION
Conduction-
Conduction reserved for the passage of an impulse
along an axon or muscle fiber;
Transmission- the passage of an impulse across a
synaptic or neuro-effector junction.
Very few drugs (Local anesthetics) modify axonal
conduction in the doses employed therapeutically
therapeutically.
14
17. Divisions o t e PAS
s o s of the S
Acetylcholine is neurotransmitter:-
All preganglionic autonomic fibers
fibers,
All postganglionic parasympathetic fibers, and
A few postganglionic sympathetic fibers
Cholinergic fibers use Ach
Adrenergic fibers comprise
majority of postganglionic sympathetic fibers;
transmitter is norepinephrine (noradrenaline)
17
18. Skeletal Muscle
Stimulation of a motor nerve results in the release of ACh
The combination of ACh with nicotinic ACh receptors induces
an immediate, marked increase in cation permeability
About 50,000 Na+ ions traverse the channel
The channel-opening process is the basis for the localized
depolarizing
which triggers the muscle AP leads to contraction
Autonomic Effectors
ff
Stimulation of autonomic effector cells occurs on
activation of muscarinic acetylcholine receptors.
18
19. Autonomic Nervous System Drugs
Autonomic nervous system drugs work either by:
acting like neurotransmitters or
by interfering with neurotransmitter release
Two groups of drugs affect the parasympathetic
nervous system
Cholinergic
Anticholinergic
Muscarinic antagonists
Nicotinic t
Ni ti i antagonists
it
Two groups of drugs affect the sympathetic nervous
system:
Adrenergic and antiadrenergics
19
21. Cholinergic Drugs
Mimic the action of the parasympathetic nervous system
A. Muscarinic Agonists /Direct Acting
Direct
Cholinomimetics
Cholinomimetic alkaloids:
Muscarine, Pilocarpine
, p
Ach and Choline esters
Acetylcholine, Methacholine, Carbachol,
Bethanechol
B h h l
21
23. Malathion and Parathion
Pralidoxime (2 PAM) is a mechanism based antidote for poisoning
(2-PAM)
Anticholinestrase poisoning is reversed by
Atropine- counteract the muscarinic action and
Pralidoxime- reactivate AChE
23
24. Summary of cholinergics
Cholinergics Acetylcholine
Bethanechol
Direct acting Carbachol
Cevimeline
C
Pilocarpine
Ambenomium
Donepezil
p
Indirect acting Edrophonium
(reversible) Galantamine
Neostigmine
Physostigmine
Pyridostigmine
P id i i
Rivastigmine
Tacrine
Indirect acting
g
(irreversible) Echothiophate
Isoflurophate
(according to Lippincott´s Pharmacology, 2006)
24
26. Anticholinergic Drugs
Inhibit the actions of ACh by occupying the acetylcholine
receptors
Competitive (reversible) antagonists of Ach
Pharmacologic effects opposite of the muscarinic agonists
Antagonistic responses i
i i include:
decreased contraction of GI and urinary tract smooth muscles,
dilation of pupils,
p p ,
reduced gastric secretion,
decreased saliva secretion.
26
27. Anticholinergic Drugs
Examples include:
Solanaceous Alkaloids
Atropine and Scopolamine
Semi-synthetics
Homatropine, metscopolamine
Synthetic congeners
Clidinium,Telenzepine, P
Clidi i Tl i Propantheline, I
h li Ipratropium
i
Benztropine, etc
27
28. Indications Antimuscarinics
Preanesthetics= Used preoperatively
Atropine, hyoscine
GIT
Relax smooth m/s-
propantheline, hyoscine, clindinium, dicycloamine
Facilitate endoscopy-
Hyoscine
Irritable bowel syndrome-
syndrome
dicycloamine
Peptic ulcer-
p
pirenzepine, telenzepine
p p
Ophthalmic- to dilate the pupil
Atropine, scopolamine,tropicamide
28
29. III. NICOTINIC ANTAGONISTS
III
Two b l
T subclasses:
1.
1 Skeletal neuromuscular blocking agents and
2. Ganglionic blocking agents.
29
30. 1. Skeletal neuromuscular blocking
agents
A. Depolarizing Agent
Succinylcholine/ suxamethonium
Decamethonium
Initially depolarizes like Ach but persistent depolarization of
y p p p
nicotinic receptors at NMJ leads to repolarization
Decrease Ach release
m/s relaxation
/ l
Concurrent use of AChE inhibitors aggravate it
Toxicity is not reversed by use of AChE inhibitors to increase of
Ach
Action is terminated by plasma cholinesterase
yp
30
31. Skeletal neuromuscular blocking agents
B. Non-depolarizing agent= stabilizing=
co pet t ve blocking age ts
competitive b oc g agents
Short acting:
Mivacurarium
Intermediate Acting:
I di A i
Vecuronium, Rocuronium, Atracurarium,
Long acting:
Tubocororium, pancuronium, gallamine
Competitively displace Ach and prevent depolarization of the
C i i l di l A h d d l i i f h
endplate.
31
32. Tubocurarine and derivatives
Plant alkaloid from Chondodendron tomentosum
tomentosum.
Causes muscle paralysis (arrow poison).
Rapid onset of action
Metocurine is a semi-synthetic analog of tubocurarine.
semi synthetic
More potent than the parent compound.
Therapeutic Use:
As a muscle relaxant in various surgical procedures.
32
33. Botulinum Toxin (Botox)
Toxin produced by the bacterium Clostridium botulinum
Causes food poisoning; Large doses can be fatal
Prevents Acetylcholine release from the nerve terminal
Produces flaccid paralysis of skeletal muscle
p y
Inhibition lasts from several weeks to 3 to 4 months.
Therapeutic Uses:
Administered locally, via im or intradermal injections, to
control muscle spasms and to facilitate muscle
relaxation (
l i (eye; f
face; neck etc.)
k )
Dermatological / Cosmetic Uses in human:
To treat facial wrinkles (forehead; under the eyes etc.)
( ; y )
Prevent excessive sweating (palm; armpit etc)
33
34. 2. Ganglionic blocking agents
A. Nicotine
at low dose Stimulate ganglia initially like Ach by
depolarizing the excitatory postsynaptic membranes.
At high dose, block the ganglia b/c of persistent
depolarization
d l i i
B. Hexamethonium Trimethaphan, Mecamylamine
B Hexamethonium,Trimethaphan
Impair transmission
Compete with Ach for nicotinic receptor
Trimethaphan
Block the channel after it opens
Hexamethonium
34
35. Adrenergic Drugs
Simulate the action of the sympathetic nervous system
Examples include:
p
epinephrine, norepinephrine, isoproterenol, dopamine,
dobutamine, phenylpropanolamine, isoetharine, albuterol,
terbutaline, ephedrine, and xylazine
, p , y
Adrenergic receptors are divided into two major types
according to drug potency on the receptors
g gp y p
Alpha-(α-) adrenergic receptors
E > NE >> isoproterenol
p
Beta-(β-) adrenergic receptors
isoproterenol > E > NE
35
36. α-Adrenergic Receptors
α1 α2
Type “Vascular” “Presynaptic”
D istribution Blood vessels, G sphincters,
IT, A utonom nerve term
ic inals, blood
iris radial, liver vessels, pancreatic islets, platelets
R eceptor
eceptor- GPCR, linked to activation of
q GPCR, linked to inhibition of
i
Transduction PLC-DA -IP3G adenyl cyclase-c.A P
M
A gonist E=N E>>>ISO P E=N E>>>ISO P
Profile
Selective Phenylephrine &m ethoxamine Clonidine, α-M O
eD PA
A gonists
Selective Prazocin Y bine
ohim
Antagonists
36
40. Adrenergic Blocking Agents
Block the effects of the adrenergic neurotransmitters
Examples of alpha-blockers include:
phenoxybenzamine, prazosin,
phenoxybenzamine prazosin and yohimbine
Examples of beta-blockers include:
beta blockers
propranolol, metoprolol, and timolol
40
41. Sites of Actions of
Anti adrenergic
Anti-adrenergic Drugs
VMC (α2 )
Adrenergic Nerve
terminal
Heart
Ganglia BV
Effectors cell
( α & β)
1. Central blockers
2. Ganglionic blockers
3. Adrenergic Nerve terminal
Blockers
4. Adrenergic Receptor
g
Blockers
41 • Alpha Blockers
41
• Beta Blockers